• Home  / 
  • Anxiety
  •  /  MorphoSys and Galapagos Start First-In-Patient Dosing of IL-17C Antibody MOR106 in Atopic Dermatitis – PharmiWeb.com (press release)

MorphoSys and Galapagos Start First-In-Patient Dosing of IL-17C Antibody MOR106 in Atopic Dermatitis – PharmiWeb.com (press release)

About the author

Click here to add a comment

Leave a comment: